Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Rothenfusser K
763113-22-0
Characterization of EHT 1864
PubMed PMID: 23828641
ENMD-2076 tartrate - CAS# 1291074-87-7 lol metabolite 4-Hydroxyphenyl Carvedilol Rothenfusser KENMD 2076 is an orally active, Aurora A angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD 2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over expressed in human cancers. ENMD 2076 also targets the VEGFR, Flt 3 and FGFR3 kinases which have been
US$ 11.95
US$ 154.95
US$ 16.95
US$ 154.95
US$ 25.00
US$ 65.00
US$ 15.00
US$ 18.00
US$ 25.00